Lung Cancer (EGFR Mutation): Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of 58 year old previously healthy male who presents with papillary thyroid cancer (PTC) with metastasis to lungs, neck/chest lymph nodes and possibly bone.

Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim a CME, completion, or participation certificate for completing this activity.

Learning Objectives

  • Analyze the molecular testing options available for Non- Small Cell Lung Cancer and apply predictive biomarker testing guidelines
  • Discuss the clinical trial data on first line treatment therapies for patients with non-small cell lung cancer harboring mutations in the epidermal growth factor receptor (EGFR)
  • Discuss the management of patients with non-small cell lung cancer who develop acquired resistance  to EGFR tyrosine kinase inhibitors

This activity was made available on 12/16/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(s) ™ credit is available.

Competencies Addressed

Medical Knowledge (ACGME, AAPA)

Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)